Alan B. Lancz & Associates’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,240
Closed -$126K 138
2023
Q1
$126K Hold
1,240
0.13% 173
2022
Q4
$141K Buy
+1,240
New +$128K 0.14% 176
2022
Q3
Sell
-1,240
Closed -$135K 160
2022
Q2
$135K Sell
1,240
-532
-30% -$60.4K 0.13% 168
2022
Q1
$210K Hold
1,772
0.19% 138
2021
Q4
$249K Buy
+1,772
New +$227K 0.22% 123

Other funds holding ABT

Alan B. Lancz & Associates's ABT Position: Q2 2023 in Review

Alan B. Lancz & Associates sold out of Abbott (ABT) in Q2 2023, closing a stake of 1,240 shares — an estimated $126K sold.

Alan B. Lancz & Associates first reported a position in ABT in Q4 2021 and held it in 5 quarters. The position peaked at $249K in Q4 2021. 2,737 funds tracked by Wall St. Rank hold ABT as of Q2 2023.

  • Alan B. Lancz & Associates reported no remaining Abbott position as of Q2 2023 after selling out during the quarter.
  • Alan B. Lancz & Associates sold 1,240 Abbott shares in Q2 2023, an estimated $126K.
  • Alan B. Lancz & Associates first reported a position in Abbott in Q4 2021 and held it in 5 quarters.
  • Alan B. Lancz & Associates's Abbott position peaked at $249K in Q4 2021.
  • 2,737 funds tracked by Wall St. Rank held Abbott as of Q2 2023.

Based on Alan B. Lancz & Associates's 13F filing for Q2 2023, filed 9 Aug 2023.